Curcumin and Turmeric Modulate the Tumor-Promoting Effects of Iron In Vitro

References

• Gupta SC, Kismali G, and Aggarwal BB: Curcumin, a component of turmeric: from farm to pharmacy. Biofactors 39, 2–13, 2013. doi:10.1002/biof.1079
   PubMed Web of Science ®Google Scholar
• Hatcher H, Planalp R, Cho J, Torti FM, and Torti SV: Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 65, 1631–1652, 2008.
   PubMed Web of Science ®Google Scholar
• Darvesh AS, Aggarwal BB, and Bishayee A: Curcumin and liver cancer: a review. Curr Pharm Biotechnol 13, 218–228, 2012. doi: BSP/CPB/E-Pub/000148-12-10 [pii]
   PubMed Web of Science ®Google Scholar
• Huang MT, Newmark HL, and Frenkel K: Inhibitory effects of curcumin on tumorigenesis in mice. J Cell Biochem Suppl 27, 26–34, 1997.
   PubMedGoogle Scholar
• Brissot P, Ropert M, Le Lan C, and Loreal O: Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim Biophys Acta 1820, 403–410, 2012. doi:10.1016/j.bbagen.2011.07.014, S0304-4165(11)00180-2 [pii]
   PubMed Web of Science ®Google Scholar
• Hsing AW, McLaughlin JK, Olsen JH, Mellemkjar L, Wacholder S, et al.: Cancer risk following primary hemochromatosis: a population-based cohort study in Denmark. Int J Cancer 60, 160–162, 1995.
   PubMed Web of Science ®Google Scholar
• Deugnier Y and Turlin B: Iron and hepatocellular carcinoma. J Gastroenterol Hepatol 16, 491–494, 2001.
   PubMed Web of Science ®Google Scholar
• Kowdley KV: Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology 127, S79–S86, 2004.
   PubMed Web of Science ®Google Scholar
• Kew MC: Hepatic iron overload and hepatocellular carcinoma. Liver Cancer 3, 31–40, 2014. doi:10.1159/000343856, lic-0003-0031 [pii]
   PubMed Web of Science ®Google Scholar
• Huang X: Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. Mutat Res 533, 153–171, 2003.
   PubMed Web of Science ®Google Scholar
• Messner DJ and Kowdley KV: Neoplastic transformation of rat liver epithelial cells is enhanced by non-transferrin-bound iron. BMC Gastroenterol 8, 2, 2008.
   PubMed Web of Science ®Google Scholar
• Maeda S, Kamata H, Luo JL, Leffert H, and Karin M: IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121, 977–990, 2005.
   PubMed Web of Science ®Google Scholar
• Baum L and Ng A: Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. J Alzheimers Dis 6, 367–377; discussion 443–449, 2004.
   PubMed Web of Science ®Google Scholar
• Bernabe-Pineda M, Ramirez-Silva MT, Romero-Romo MA, Gonzalez-Vergara E, and Rojas-Hernandez A: Spectrophotometric and electrochemical determination of the formation constants of the complexes Curcumin-Fe(III)-water and Curcumin-Fe(II)-water. Spectrochim Acta A Mol Biomol Spectrosc 60, 1105–1113, 2004.
   PubMed Web of Science ®Google Scholar
• Messner DJ, Sivam G, and Kowdley KV: Curcumin reduces the toxic effects of iron loading in rat liver epithelial cells. Liver Int 29, 63–72, 2009.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Rhizoma Curcumae Longae. In: WHO Monographs on Selected Medicinal Plants. Geneva: World Health Organization, 1999, pp. 115–124.
   Google Scholar
• Boynton AL, Kleine LP, and Whitfield JF: Relation between colony formation in calcium-deficient medium, colony formation in soft agar, and tumor formation by T51B rat liver cells. Cancer Lett 21, 293–302, 1984.
   PubMed Web of Science ®Google Scholar
• Messner DJ, Ao P, Jagdale AB, and Boynton AL: Abbreviated cell cycle progression induced by the serine/threonine protein phosphatase inhibitor okadaic acid at concentrations that promote neoplastic transformation. Carcinogenesis 22, 1163–1172, 2001.
   PubMed Web of Science ®Google Scholar
• Swierenga SH, Whitfield JF, Boynton AL, MacManus JP, Rixon RH, et al.: Regulation of proliferation of normal and neoplastic rat liver cells by calcium and cyclic AMP. Ann N Y Acad Sci 349, 294–311, 1980.
   PubMedGoogle Scholar
• Colburn NH, Bruegge WF, Bates JR, Gray RH, Rossen JD, et al.: Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cells. Cancer Res 38, 624–634, 1978.
   PubMed Web of Science ®Google Scholar
• Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, et al.: A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 12, 410–416, 2006. doi: nm1377 [pii], 10.1038/nm1377
   PubMed Web of Science ®Google Scholar
• Grootveld M, Bell JD, Halliwell B, Aruoma OI, Bomford A, et al.: Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J Biol Chem 264, 4417–4422, 1989.
   PubMed Web of Science ®Google Scholar
• Eaton JW and Qian M: Molecular bases of cellular iron toxicity. Free Radic Biol Med 32, 833–840, 2002.
   PubMed Web of Science ®Google Scholar
• Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar KB, et al.: Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol 76, 1590–1611, 2008. doi:10.1016/j.bcp.2008.08.008, S0006-2952(08)00554-6 [pii]
   PubMed Web of Science ®Google Scholar
• Goto Y, Paterson M, and Listowsky I: Iron uptake and regulation of ferritin synthesis by hepatoma cells in hormone-supplemented serum-free media. J Biol Chem 258, 5248–5255, 1983.
   PubMed Web of Science ®Google Scholar
• Hann HW, Stahlhut MW, and Hann CL: Effect of iron and desferoxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines. Hepatology 11, 566–569, 1990.
   PubMed Web of Science ®Google Scholar
• Farber E: Some emerging general principles in the pathogenesis of hepatocellular carcinoma. Cancer Surv 5, 695–718, 1986.
   PubMedGoogle Scholar
• Fausto N: Mouse liver tumorigenesis: models, mechanisms, and relevance to human disease. Semin Liver Dis 19, 243–252, 1999.
   PubMed Web of Science ®Google Scholar
• Hartwig A, Klyszcz-Nasko H, Schlepegrell R, and Beyersmann D: Cellular damage by ferric nitrilotriacetate and ferric citrate in V79 cells: interrelationship between lipid peroxidation, DNA strand breaks and sister chromatid exchanges. Carcinogenesis 14, 107–112, 1993.
   PubMed Web of Science ®Google Scholar
• Hartwig A and Schlepegrell R: Induction of oxidative DNA damage by ferric iron in mammalian cells. Carcinogenesis 16, 3009–3013, 1995.
   PubMed Web of Science ®Google Scholar
• Iqbal M, Giri U, and Athar M: Ferric nitrilotriacetate (Fe-NTA) is a potent hepatic tumor promoter and acts through the generation of oxidative stress. Biochem Biophys Res Commun 212, 557–563, 1995.
   PubMed Web of Science ®Google Scholar
• Yamada M, Awai M, and Okigaki T: Rapid in vitro transformation system for liver epithelial cells by iron chelate, Fe-NTA. Cytotechnology 3, 149–156, 1990.
   PubMed Web of Science ®Google Scholar
• Jiao Y, Wilkinson JT, Christine Pietsch E, Buss JL, Wang W, et al.: Iron chelation in the biological activity of curcumin. Free Radic Biol Med 40, 1152–1160, 2006.
   PubMed Web of Science ®Google Scholar
• Jiao Y, Wilkinson JT, Di X, Wang W, Hatcher H, et al.: Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator. Blood 113, 462–469, 2009. doi:10.1182/blood-2008-05-155952, blood-2008-05-155952 [pii]
   PubMed Web of Science ®Google Scholar
• Garcea G, Jones DJ, Singh R, Dennison AR, Farmer PB, et al.: Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br J Cancer 90, 1011–1015, 2004.
   PubMed Web of Science ®Google Scholar
• Ferrari E, Arezzini B, Ferrali M, Lazzari S, Pignedoli F, et al.: Synthesis and characterization of glucosyl-curcuminoids as Fe3+ suppliers in the treatment of iron deficiency. Biometals 22, 701–710, 2009. doi:10.1007/s10534-009-9213-8
   PubMed Web of Science ®Google Scholar